| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000037752 |
| Receipt No. | R000043052 |
| Scientific Title | Effects of rice on blood glucose level : study 2 |
| Date of disclosure of the study information | 2019/10/01 |
| Last modified on | 2020/02/20 (Ver. 2) |
| Basic information | ||
| Public title | Effects of rice on blood glucose level :
study 2 |
|
| Acronym | Effects of rice on blood glucose level :
study 2 |
|
| Scientific Title | Effects of rice on blood glucose level :
study 2 |
|
| Scientific Title:Acronym | Effects of rice on blood glucose level :
study 2 |
|
| Region |
|
|
| Condition | ||
| Condition | healthy adult male | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study examines effects of rice on blood glucose level |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Glycemic Index (GI) |
| Key secondary outcomes | Incremental area under the blood glucose response curve (IAUC)
Peak of blood glucose level Transition of blood glucose level Questionnaires of test food |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -investigator(s) and assessor(s) are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 6 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | standard rice, rice a, rice f, rice e, rice d, rice c, rice b | |
| Interventions/Control_2 | standard rice, rice b, rice a, rice f, rice e, rice d, rice c | |
| Interventions/Control_3 | standard rice, rice c, rice b, rice a, rice f, rice e, rice d | |
| Interventions/Control_4 | standard rice, riced, rice c, ric eb, rice a, rice f, rice e | |
| Interventions/Control_5 | standard rice, rice e, riced, rice c, rice b, rice a, rice f | |
| Interventions/Control_6 | standard rice, rice f, rice e, rice d, rice c, rice b, rice a | |
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1. Japanese healthy men aged 20-50years
2. BMI of 20-25 kg/m2 3. Individuals who can visit hospital on specified days 4. Individuals whose written informed consent has been obtained |
|||
| Key exclusion criteria | 1.Individuals who have allergic reaction to rice, wheat, barley, egg and milk
2.Individuals who have history of severe disorder and surgical disorder 3.Individuals who have medical disorder, cardiovascular, hepatic and kidney disorder, including complication of other disorder in preliminary examination 4.Individuals suspected of infectious disorder from results immunological examination 5.Individuals who have presence or previous history of gastrointestinal disease, or surgical history for excision of the gastrointestinal tract, gastric ulcer, peptic ulcer etc. 6.Individuals who have history of thyroid disorder 7.Individuals whose fasting glucose level are not 70-109 mg/dL 8.Individuals who have a difference within 25% in the IAUC of two preliminary examinations 9.Individuals diagnosed as impaired glucose tolerance in the past year 10.Individuals who donated blood (blood donation etc.) exceeding 200 mL within 4 weeks, 400 mL within 4 months or, 1200 mL within 12 months 11.Individuals participating in any other long clinical study involving human subjects within 4 weeks or currently participating in any other clinical study involving human subjects. 12.Individuals with excessive alcohol drinking or smokers 13.Individuals who can not eat regularly 14.Individuals currently intaking medicine, health food product or a supplement 15.Individuals who have experienced a feeling of unwellness or bad physical condition by blood drawing. 16.Individuals judged inappropriate for the trial by the principal |
|||
| Target sample size | 12 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Ajinomoto Co., Inc. | ||||||
| Division name | Human health & nutrition group, Institute of food sciences & technologies | ||||||
| Zip code | 2108681 | ||||||
| Address | 1-1, Suzuki-tyo, Kawasaki-ku, Kawasaki-shi, Kanagawa | ||||||
| TEL | 044-223-4114 | ||||||
| tomoyuki_mine@ajinomoto.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Ajinomoto Co., Inc. | ||||||
| Division name | Human health & nutrition group, Institute of food sciences & technologies | ||||||
| Zip code | 2108681 | ||||||
| Address | 1-1, Suzuki-tyo, Kawasaki-ku, Kawasaki-shi, Kanagawa | ||||||
| TEL | 044-223-4114 | ||||||
| Homepage URL | |||||||
| naoko_fujimura@ajinomoto.com | |||||||
| Sponsor | |
| Institute | Medical Corporation Hokubukai Utsukushigaoka Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ajinomoto Co., Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Clinical Support Corporation |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Medical Corporation Hokubukai Utsukushigaoka Hospital ethical review committee |
| Address | 61-1, Shinei, Kiyota-ku, Sapporo-shi, Hokkaido |
| Tel | 011-882-0111 |
| info@csc-smo.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人 北武会 美しが丘病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000043052 |